Blockade of FGF signaling: therapeutic promise for ovarian cancer.
Ivan
Mircea
M
Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA mivan@iupui.edu
Matei
Daniela
D
D017398:Alternative Splicing; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use*; D005260:Female; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000378:metabolism*; D015870:Gene Expression; D006801:Humans; D008024:Ligands; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism*; D017468:Receptors, Fibroblast Growth Factor / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction
D000970:Antineoplastic Agents; D008024:Ligands; D017468:Receptors, Fibroblast Growth Factor; D005346:Fibroblast Growth Factors; D002945:Cisplatin